Sort
64,565 grants matching “drug discovery”
Structural Biology
$613,728Yehuda Goldgur · Sloan-Kettering Inst Can Research · P30 · FY2025 · CA
Antitumor Assessment
$613,728Elisa De Stanchina · Sloan-Kettering Inst Can Research · P30 · FY2025 · CA
Genomic Editing & Screening
$613,727Ralph J. Garippa · Sloan-Kettering Inst Can Research · P30 · FY2025 · CA
Spatiotemporal signaling and trafficking of the mu-opioid receptor
$613,700Ruth Huttenhain · University Of California, San Francisco · R01 · FY2022 · DA
SPHINGOLIPID BIOLOGY OF MACROPHAGE IN CORONARY ATHEROSCLEROSIS DEVELOPMENT AND PROGRESSION
$613,659Annarita Di Lorenzo · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · HL
NOTCH3 ECD as a Serum Biomarker for Pulmonary Arterial Hypertension
$613,624Patricia A Thistlethwaite · University Of California, San Diego · R01 · FY2025 · HL
ALZHEIMERS RESEARCH PROJECT: Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease)
$613,612Nigel H. Greig · National Institute On Aging · ZIA · FY2024 · AG
Cancer Research Training in Molecular Biology
$613,502Amy H Bouton · University Of Virginia · T32 · FY2009 · CA
Effectors of Cellular Senescence States
$613,494John M. Sedivy · Brown University · R01 · FY2023 · AG
Effectors of Cellular Senescence States
$613,494John M. Sedivy · Brown University · R01 · FY2020 · AG
Effectors of Cellular Senescence States
$613,494John M. Sedivy · Brown University · R01 · FY2022 · AG
Effectors of Cellular Senescence States
$613,494John M. Sedivy · Brown University · R01 · FY2024 · AG
Effectors of Cellular Senescence States
$613,494John M. Sedivy · Brown University · R01 · FY2021 · AG
Profiling Ras Activated Signal Transduction Pathways
$613,471University Of California Irvine · R33 · FY2002 · CA
Using patient-derived models to understand drug responses in SCLC
$613,419Nicholas J Dyson · Massachusetts General Hospital · U01 · FY2021 · CA
Biochemistry of Protein Prenylation
$613,376Michael H Gelb · University Of Washington · R01 · FY2011 · AI
Adjuvant Therapies Improving the Anti-Rejection Effects of Costimulation Blockade
$613,352Allan D. Kirk · Emory University · U01 · FY2010 · AI
Graduate Training in Cellular and Molecular Pharmacology
$613,291Joan Heller Brown · University Of California, San Diego · T32 · FY2016 · GM
MOUSE MODELS OF GASTROINTESTINAL CANCER
$613,279University Of Cincinnati · U01 · FY2003 · CA
Optimization of biliverdin IXβ reductase redox inhibitors as novel reagents for enhancing platelet production
$613,208Natasha M. Nesbitt · Blood Cell Technologies, Llc · R44 · FY2023 · HL
Identification and characterization of functional genetic variants associated with human longevity
$613,199Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2023 · AG
Phase 2 Proof-of-Concept Efficacy of BT-11 in Crohn's Disease Patients
$613,188Simon Lichtiger · Landos Biopharma, Inc. · R01 · FY2022 · DK
Chemoprevention of experimental tobacco tumorigenesis.
$613,122University Of Louisville · R01 · FY2003 · CA
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
$613,109Molly A Hughes · University Of Virginia · R01 · FY2023 · AI
Integrative Analysis of Genomic, Epigenomic and Phenotypic Data for Disease Stratification of Endometriosis
$613,083Linda C Giudice · University Of California, San Francisco · R01 · FY2018 · HD